324
Participants
Start Date
May 31, 2005
Primary Completion Date
August 31, 2008
cisplatin
25 mg/m2 in 1000 mls 0.9% saline given over 1 hour followed by 500 mls 0.9% saline over 90 mins
gemcitabine hydrochloride
1000mg/m2 in 250-500mls 0.9% saline over 30 mins by intravenous infusions on day 1, 8 and 15 (Arm A only) of each 28 (Arm A) or 21 (Arm B) day cycle.
Basingstoke and North Hampshire NHS Foundation Trust, Basingstoke
Queen Elizabeth Hospital at University Hospital of Birmingham NHS Trust, Birmingham
Addenbrooke's Hospital, Cambridge
Cumberland Infirmary, Carlisle
Gloucestershire Oncology Centre at Cheltenham General Hospital, Cheltenham
Derbyshire Royal Infirmary, Derby
Princess Alexandra Hospital, Essex
Gloucestershire Royal Hospital, Gloucester
Princess Royal Hospital at Hull and East Yorkshire NHS Trust, Hull
Leeds Cancer Centre at St. James's University Hospital, Leeds
Helen Rollason Cancer Care Centre at North Middlesex Hospital, London
Royal Marsden - London, London
Hammersmith Hospital, London
UCL Cancer Institute, London
University College of London Hospitals, London
Maidstone Hospital, Maidstone
Clatterbridge Centre for Oncology, Merseyside
Mount Vernon Cancer Centre at Mount Vernon Hospital, Northwood
Nottingham City Hospital, Nottingham
Portsmouth Oncology Centre at Saint Mary's Hospital, Portsmouth Hants
Cancer Research Centre at Weston Park Hospital, Sheffield
Belfast City Hospital Trust Incorporating Belvoir Park Hospital, Belfast
Aberdeen Royal Infirmary, Aberdeen
Velindre Cancer Center at Velindre Hospital, Cardiff
Glan Clwyd Hospital, Rhyl, Denbighshire
Eli Lilly and Company
INDUSTRY
University College, London
OTHER